Agreement award for budesonide with eformoterol powder for inhalation
Published 16 Mar 2022
New Zealand
Pharmaceutical Management Agency
Agreement award for budesonide with eformoterol powder for inhalation
Pharmaceutical Management Agency
Contract details
As part of a wider decision to fund new treatments for cancer and asthma Pharmac is amending and extending the terms of agreement with AstraZeneca Pty Ltd for budesonide with eformoterol dry powder inhalers (Symbicort Turbuhaler) You can read the full details of the decision on…
Create an account to view the complete contract overview and award information.
Regions
Categories
Buyer
25517848
Awarded suppliers
View awarded suppliers
Upgrade to Pro to identify the organisations awarded this contract and access their supplier profiles.
Similar opportunities
Finding tenders with similar work types, categories, locations, or project scope.